Xceed Molecular Company Description
Xceed Molecular (formerly MetriGenix) is working to exceed the expectations of researchers performing gene expression tests. The company's flow-thru chip technology is used by biotechnology and pharmaceutical companies for genetic screening. Ore Pharmaceuticals (formerly Gene Logic) owns a minority stake in Xceed Molecular, which was established in 2001. The company has facilities in Canada and the US. In mid-2005, the company acquired GeneXP Biosciences, a maker of gene expression biomarker tests.
View the Comprehensive Company Description for Xceed Molecular
The Company Description provides a historical perspective of Xceed Molecular's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Xceed Molecular's evolution in the marketplace.
